首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

2032929

胰臟癌治療和診斷市場報告：按類型、應用和地區分類 2026-2034 年

Pancreatic Cancer Therapeutics and Diagnostics Market Report by Type (Diagnostics, Treatment), Application (Hospitals, Clinics, and Others), and Region 2026-2034

出版日期: 2026年04月01日 | 出版商:

IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2025年，全球胰臟癌治療和診斷市場規模達48億美元。展望未來，IMARC Group預測，該市場從2026年到2034年將以5.94%的複合年成長率成長，到2034年達到82億美元。醫療保健行業的快速發展、胰腺癌發病率的上升以及對化療以殺死胰腺癌細胞的需求不斷成長，是推動該市場發展的主要因素。

胰臟癌的治療方法和診斷方法是指用於診斷和治療胰臟癌的醫療程序。這些治療方法和診斷方法包括超音波、電腦斷層掃描（CT）、磁振造影（MRI）和正子斷層掃描（PET）。其中一項重要技術是超音波（EUS），它利用超音波設備從腹腔內對胰臟進行成像。這些方法有助於監測胰臟內細胞不受控制增生引起的腫瘤的位置。它們還有助於進行切片檢查，即採集少量組織樣本在顯微鏡下進行檢查。此外，它們還有助於進行一些臨床檢查，例如血液常規檢查（CBC）、肝臟酵素檢查（用於檢查膽道阻塞）以及空腹血糖值和醣化血紅素（HbA1c）檢查。因此，胰臟癌的治療方法和診斷方法在全球各地的醫院和專科醫療中心廣泛應用。

胰臟癌治療與診斷市場的發展趨勢：

目前，人口老化和公眾吸菸率上升導致胰臟癌發病率不斷攀升，這是推動市場成長的主要因素之一。此外，分子生物學、製藥和診斷技術的進步在全球範圍內不斷推進。這些因素，加上蓬勃發展的醫療保健產業，共同促進了市場成長。同時，對抑制胰臟癌細胞增殖和分裂並殺死癌細胞的化療的需求日益成長，也對市場產生了積極影響。許多國家的監管機構正積極投資於胰臟癌的臨床試驗以及去氧核糖核酸修復抑制劑與化療聯合應用的研究。他們也致力於透過核准臨床試驗藥物來加速胰臟癌治療和診斷的發展。此外，業界領先企業正在推出人源化單株抗體，以促進抗腫瘤免疫反應，用於治療食道癌、胃食道交界處癌和胰臟癌。他們也正在開發和推出基於試劑盒的檢測方法，透過識別 BRCA1 和 BRCA2 突變並評估基因組不穩定性來檢測胰臟癌，預計這將在未來幾年促進市場成長。

本報告解答的主要問題

全球胰臟癌治療與診斷市場迄今為止的發展軌跡如何？未來幾年預計會出現哪些趨勢？
全球胰臟癌治療和診斷市場的促進因素、阻礙因素和機會是什麼？
主要區域市場有哪些？
哪個國家的胰臟癌治療和診斷市場最具吸引力？
按類型分類的市場組成是什麼？
在胰臟癌治療和診斷市場中，哪種類型最具吸引力？
按應用領域分類的市場區隔如何？
胰臟癌治療和診斷市場中最具吸引力的應用有哪些？
全球胰臟癌治療與診斷市場的競爭格局如何？
全球胰臟癌治療和診斷市場的主要參與者/公司有哪些？

The global pancreatic cancer therapeutics and diagnostics market size reached USD 4.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.94% during 2026-2034. The burgeoning healthcare industry, rising prevalence of pancreatic cancer, and the escalating demand for chemotherapy to kill pancreatic cancer cells represent some of the key factors driving the market.

Pancreatic cancer therapeutics and diagnostics are medical procedures used to diagnose pancreatic cancer and provide treatment. These therapeutics and diagnostics comprise ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI) , and positron emission tomography (PET) scans. They rely on an endoscopic ultrasound (EUS) that uses an ultrasound device to produce images of the pancreas from inside the abdomen. They help in monitoring the location of the tumor due to an uncontrollable growth of cells in the pancreas. They assist in performing a biopsy to remove a small sample of tissue for examination under a microscope. They also aid in laboratory investigations, such as a complete blood count (CBC), liver enzyme tests for biliary obstruction, and fasting glucose and glycated hemoglobin (HbA1C) tests. As a result, pancreatic cancer therapeutics and diagnostics find applications in hospitals and specialty centers across the globe.

PANCREATIC CANCER THERAPEUTICS AND DIAGNOSTICS MARKET TRENDS:

At present, the rising prevalence of pancreatic cancer due to the increasing geriatric population and excessive smoking habits among the masses represents one of the key factors supporting the growth of the market. Besides this, there is an increase in the development of molecular biology, drugs, and diagnostic technology around the world. This, along with the thriving healthcare industry, is currently propelling the growth of the market. In addition, the escalating demand for chemotherapy to kill pancreatic cancer cells by preventing them from growing and dividing is positively influencing the market. Moreover, governing agencies of several countries are extensively investing in pancreatic cancer clinical trial testing and deoxyribonucleic acid (DNA) repair inhibitors combined with chemotherapy. They are also focusing on enhancing the growth of pancreatic cancer therapeutics and diagnostics by approving drugs in the clinical phase. Apart from this, key players operating in the industry are introducing a humanized monoclonal antibody that promotes the anti-tumor immune response for treating esophageal and gastroesophageal junction and pancreatic cancer. They are also developing and introducing kit-based testing to detect pancreatic cancer by determining BRCA1 and BRCA2 variants and assessing genomic instability, which is projected to contribute to the growth of the market in the coming years.

KEY MARKET SEGMENTATION:

Type Insights:

Diagnostics
- Imaging
- Biopsy
- Endoscopic Ultrasound
- Others
Treatment
- Targeted Therapies
- Chemotherapy
- Surgery
- Others

Application Insights:

Hospitals
Clinics

Regional Insights:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for pancreatic cancer therapeutics and diagnostics. Some of the factors driving the North America pancreatic cancer therapeutics and diagnostics market included advancements in diagnostic technologies, emerging therapies and treatment options, increasing healthcare expenditure, and government initiatives and funding.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global pancreatic cancer therapeutics and diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies include AstraZeneca plc, F. Hoffmann-La Roche Ltd., Immunovia AB, Novartis AG, Pfizer Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

How has the global pancreatic cancer therapeutics and diagnostics market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global pancreatic cancer therapeutics and diagnostics market?
What are the key regional markets?
Which countries represent the most attractive pancreatic cancer therapeutics and diagnostics markets?
What is the breakup of the market based on the type?
Which is the most attractive type in the pancreatic cancer therapeutics and diagnostics market?
What is the breakup of the market based on the application?
Which is the most attractive application in the pancreatic cancer therapeutics and diagnostics market?
What is the competitive structure of the global pancreatic cancer therapeutics and diagnostics market?
Who are the key players/companies in the global pancreatic cancer therapeutics and diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Pancreatic Cancer Therapeutics and Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Diagnostics
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Imaging
  - 6.1.2.2 Biopsy
  - 6.1.2.3 Endoscopic Ultrasound
  - 6.1.2.4 Others
- 6.1.3 Market Forecast
6.2 Treatment
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Targeted Therapies
  - 6.2.2.2 Chemotherapy
  - 6.2.2.3 Surgery
  - 6.2.2.4 Others
- 6.2.3 Market Forecast

7 Market Breakup by Application

7.1 Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Clinics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

9.1 Overview
9.2 Drivers
9.3 Restraints
9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 AstraZeneca plc
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 F. Hoffmann-La Roche Ltd.
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
- 13.3.3 Immunovia AB
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
- 13.3.4 Novartis AG
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 Pfizer Inc.
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 Financials
  - 13.3.5.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Type (in %), 2025
Figure 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Application (in %), 2025
Figure 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Region (in %), 2025
Figure 7: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 8: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 9: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: North America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: North America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: United States: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: United States: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: China: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: China: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: India: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: India: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: France: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: France: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Country (in %), 2025
Figure 65: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 66: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Drivers, Restraints, and Opportunities
Figure 67: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Value Chain Analysis
Figure 68: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Industry Highlights, 2025 & 2034
Table 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Type (in Million USD), 2026-2034
Table 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Application (in Million USD), 2026-2034
Table 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Competitive Structure
Table 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219